Nuveen Asset Management, LLC Bio Xcel Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$6.39 - $28.58 $297,339 - $1.33 Million	-46,532 Reduced 75.86%	14,808 $98,000
Q1 2023 May 15, 2023	SELL	$17.7 - $33.24 $2.53 Million - $4.76 Million	-143,067 Reduced 69.99%	61,340 $1.14 Million
Q4 2022 Feb 14, 2023	SELL	$10.25 - $22.43 $135,474 - $296,457	-13,217 Reduced 6.07%	204,407 $4.39 Million
Q3 2022 Nov 14, 2022	BUY	$11.19 - $17.89 $1.19 Million - $1.9 Million	106,314 Added 95.51%	217,624 $2.57 Million
Q2 2022 Aug 15, 2022	BUY	$9.03 - $21.55 $490,365 - $1.17 Million	54,304 Added 95.26%	111,310 $1.47 Million
Q1 2022 May 16, 2022	SELL	$15.0 - $22.83 $48,225 - $73,398	-3,215 Reduced 5.34%	57,006 $958,000
Q4 2021 Feb 14, 2022	BUY	$20.12 - $35.09 $275,523 - $480,522	13,694 Added 29.43%	60,221 $1.22 Million
Q3 2021 Nov 12, 2021	SELL	$23.84 - $32.03 $221,116 - $297,078	-9,275 Reduced 16.62%	46,527 $1.43 Million
Q2 2021 Aug 16, 2021	BUY	$29.06 - $38.83 $67,070 - $89,619	2,308 Added 4.31%	55,802 $1.62 Million
Q1 2021 May 17, 2021	SELL	$39.04 - $64.6 $61,527 - $101,809	-1,576 Reduced 2.86%	53,494 $2.31 Million
Q4 2020 Feb 16, 2021	SELL	$42.46 - $56.58 $1.66 Million - $2.21 Million	-39,025 Reduced 41.47%	55,070 $2.55 Million
Q3 2020 Nov 16, 2020	SELL	$37.44 - $64.63 $2.28 Million - $3.94 Million	-60,912 Reduced 39.3%	94,095 $4.08 Million
Q2 2020 Aug 14, 2020	BUY	$17.62 - $58.71 $15,170 - $50,549	861 Added 0.56%	155,007 $8.22 Million
Q1 2020 May 14, 2020	BUY	$12.26 - $41.14 $1.76 Million - $5.9 Million	143,452 Added 1341.43%	154,146 $3.45 Million
Q2 2019 Aug 15, 2019	BUY	$8.99 - $11.79 $96,139 - $126,082	10,694 New	10,694 $117,000

Others Institutions Holding BTAI

# of Institutions

Shares Held

3.11M

Call Options Held

22.2K

Put Options Held

40.2K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $8.41M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account